Products - Diet, nutrition and obesity | Topic | NICE

Showing 5 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome (review of HST31) [ID6598]
Status:
In development
Programme:
Highly specialised technologies guidance
Expected publication date:
19 August 2026
Orforglipron for managing overweight and obesity [ID6516]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
18 November 2026
Setmelanotide for treating acquired hypothalamic obesity in people 4 years and over [ID6542]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
10 February 2027
Digital technologies for multidisciplinary weight management
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
TBC
Semaglutide 7.2 mg dose for managing obesity ID6699
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
25 June 2026
Expected publication date:
TBC